ACC 2021: CONNECT-HF Provides New Data on Heart Failure Quality Improvement
The late-breaking clinical trial found no difference between the intervention group and the control group when examining an audit and feedback initiative that was hypothesized to improve heart failure care. An effort to improve the quality of heart failure care focused on audit and feedback did not significantly improve either the outcomes of patients with heart failure or the quality of care they received, according to late-breaking clinical trial results presented today at the American College of Cardiology’s 70th annual Scientific Session & Expo.
ACC 2021: ACTION Trial Shows Oral Anticoagulation with Rivaroxaban Does Not Help Patients With COVID-19
Late-breaking clinical trial results provide new insight into how to treat patients who are hospitalized with COVID-19 and at risk for blood clots. Findings from the ACTION trial, which was led by the Brazilian Clinical Research Institute in collaboration with DCRI’s Renato Lopes, MD, PhD, were presented by Lopes Sunday at the American College of Cardiology’s 70th annual Scientific Session & Expo. Results were also published after the conference in The Lancet.
ACC 2021: ADAPTABLE Answers the Aspirin Question, Provides Framework for Novel Research Methods
Results from a landmark clinical trial that sought to determine the safest and most effective dose of aspirin for patients with existing cardiovascular disease were presented Saturday morning as part of the 70th annual American College of Cardiology Scientific Session & Expo.
DCRI to Help Understand How Existing Drugs can Improve Symptoms and Clinical Outcomes for People with COVID-19
The DCRI has received $44 million in funding to examine whether three immune modulators help prevent overactive immune response in moderate or severe cases of COVID-19.
ABC Science Collaborative to Lead New Study on COVID-19 Testing in Schools
The study includes both surveillance and exposure testing to reduce COVID-19 transmission and interviews with families to increase trust within communities.
DCRI Strength in Building Networks Highlighted by Antibacterial Resistance Leadership Group Achievements
The Antibacterial Resistance Leadership Group (ARLG) involves over 100 experts, generating over 155 papers and initiating 55+ studies with 21,000 participants at 130 sites in 12 countries.
Study Shows Importance of Patient-Reported Outcomes in Heart Failure Care
More than twice as many patients saw changes in their patient-reported outcome measures compared with their traditional NYHA measures used by clinicians.
DCRI to Co-Lead Program for Self-Administered COVID-19 Testing
The program will evaluate testing results and other data to determine whether the intervention of providing self-administered COVID-19 tests helps to slow the rate of community transmission.
One Year Later: The ABC Science Collaborative Provides Evidence that Helps To Open North Carolina Schools
North Carolina models the way for national discussion and decisions on school re-openings during COVID-19 pandemic.
Pragmatic Approaches Enable Lower Burden and Cost in DCRI-led Trial
The HiLo study seeks to determine the optimal phosphate level for patients with chronic kidney disease.